Transdermal delivery of drugs for urologic applications: Basic principles and applications
- 1 April 2006
- Vol. 67 (4) , 657-664
- https://doi.org/10.1016/j.urology.2005.11.039
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Effects of Estrogen With and Without Progestin on Urinary IncontinenceJAMA, 2005
- Effect of controlled‐release delivery on the pharmacokinetics of oxybutynin at different dosages: severity‐dependent treatment of the overactive bladderBJU International, 2004
- The impact of reducing dose frequency on health outcomesClinical Therapeutics, 2003
- Clinical Pharmacokinetics of Drugs Used to Treat Urge IncontinenceClinical Pharmacokinetics, 2003
- Transdermal Drug Delivery Systems and Skin Sensitivity ReactionsAmerican Journal of Clinical Dermatology, 2000
- Skin adhesives and skin adhesionBiomaterials, 1998
- Comparison of Oxybutynin and its Active Metabolite, N-Desethyl-Oxybutynin, in the Human Detrusor and Parotid GlandJournal of Urology, 1997
- Comparison of two estradiol transdermal systems (Oesclim® 50 and Estraderm TTS® 50). I. Tolerability, adhesion and efficacyMaturitas, 1996
- Monitoring serum concentrations for once-daily netilmicin dosing regimensJournal of Antimicrobial Chemotherapy, 1994
- Transdermal drug delivery and cutaneous metabolismXenobiotica, 1987